ARBUTUS BIOPHARMA CORP's ticker is ABUS and the CUSIP is 03879J100. A total of 97 filers reported holding ARBUTUS BIOPHARMA CORP in Q3 2023. The put-call ratio across all filers is 0.90 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $16,848,610 | +157.3% | 8,299,808 | +191.5% | 0.07% | +37.5% |
| Q2 2023 | $6,547,930 | -59.6% | 2,846,926 | -46.8% | 0.05% | -32.4% |
| Q1 2023 | $16,204,295 | +43.4% | 5,347,952 | +10.2% | 0.07% | -38.8% |
| Q4 2022 | $11,303,799 | +19.3% | 4,851,416 | -2.2% | 0.12% | +38.1% |
| Q3 2022 | $9,477,000 | -25.1% | 4,961,895 | +6.3% | 0.08% | -12.5% |
| Q2 2022 | $12,651,000 | -5.3% | 4,668,227 | +4.1% | 0.10% | -47.0% |
| Q1 2022 | $13,360,000 | +90.2% | 4,483,327 | +148.3% | 0.18% | +154.9% |
| Q4 2021 | $7,024,000 | -9.0% | 1,805,700 | +0.3% | 0.07% | -32.4% |
| Q3 2021 | $7,722,000 | +41.6% | 1,800,000 | 0.0% | 0.10% | +59.1% |
| Q2 2021 | $5,454,000 | +17.0% | 1,800,000 | +28.6% | 0.07% | +15.8% |
| Q1 2021 | $4,662,000 | -9.4% | 1,400,000 | -3.4% | 0.06% | +103.6% |
| Q4 2020 | $5,148,000 | +131.7% | 1,450,000 | +104.2% | 0.03% | -15.2% |
| Q3 2020 | $2,222,000 | +25.3% | 710,000 | -27.2% | 0.03% | +6.5% |
| Q2 2020 | $1,774,000 | +119.6% | 975,000 | +21.9% | 0.03% | +55.0% |
| Q1 2020 | $808,000 | -65.8% | 800,000 | -5.9% | 0.02% | -62.3% |
| Q4 2019 | $2,363,000 | +73.1% | 850,000 | -5.0% | 0.05% | +39.5% |
| Q3 2019 | $1,365,000 | -25.9% | 895,000 | +1.1% | 0.04% | -9.5% |
| Q2 2019 | $1,841,000 | -20.9% | 885,000 | +36.2% | 0.04% | +40.0% |
| Q1 2019 | $2,327,000 | -6.5% | 650,000 | 0.0% | 0.03% | -9.1% |
| Q4 2018 | $2,490,000 | +75.6% | 650,000 | +333.3% | 0.03% | +83.3% |
| Q3 2018 | $1,418,000 | +5.0% | 150,000 | -18.9% | 0.02% | -5.3% |
| Q2 2018 | $1,351,000 | -24.9% | 185,000 | -48.6% | 0.02% | -48.6% |
| Q1 2018 | $1,800,000 | -10.9% | 360,000 | -10.0% | 0.04% | -14.0% |
| Q4 2017 | $2,020,000 | +176.0% | 400,000 | +239.0% | 0.04% | +138.9% |
| Q3 2017 | $732,000 | -31.1% | 118,000 | -60.0% | 0.02% | -14.3% |
| Q2 2017 | $1,062,000 | +26.7% | 295,000 | +14.3% | 0.02% | +90.9% |
| Q1 2017 | $838,000 | – | 257,988 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 340,000 | $1,459,000 | 0.53% |
| RTW INVESTMENTS, LP | 4,733,323 | $20,306,000 | 0.31% |
| APIS CAPITAL ADVISORS, LLC | 70,000 | $300,000 | 0.29% |
| Hudson Bay Capital Management LP | 1,800,000 | $7,722,000 | 0.10% |
| COWEN AND COMPANY, LLC | 249,215 | $1,069,000 | 0.05% |
| Kerrisdale Advisers, LLC | 100,000 | $429,000 | 0.05% |
| Woodline Partners LP | 496,172 | $2,129,000 | 0.04% |
| Shay Capital LLC | 60,000 | $257,000 | 0.03% |
| Walleye Capital LLC | 231,037 | $991,000 | 0.03% |
| BOOTHBAY FUND MANAGEMENT, LLC | 212,700 | $912,000 | 0.02% |